RFK Jr. Tried to Kill the Covid Vaccine When It Was Needed Most: Report
Robert F. Kennedy Jr. petitioned the FDA to revoke its authorization for the Covid-19 vaccine just six months after it was made available.
phillyvoice.com23m
The FDA wants to limit nicotine in cigarettes — a move that could save millions of lives
Temple pulmonologist Dr. Jamie Garfield says the proposed regulation is an effective harm reduction strategy, but suggests it ...
Hosted on MSN44m
FDA will allow Zyn nicotine pouches to stay on the market
Zyn products will be allowed to stay on the market after federal health officials said Thursday that the popular nicotine ...
Now that the FDA has banned red dye No. 3, what about more common food dyes?
Following the ban of red dye No. 3 in the United States, experts weigh in on the potential health risks of red dye No. 40, ...
Becker's Hospital Review1h
3 states get green light to sue FDA over mifepristone access
The three states argue that the FDA's approval of mifepristone for use up to 10 weeks of pregnancy, along with its availability via telemedicine and mail, has contributed to what they view as a public ...
Weight loss drug approved to treat sleep apnea
Sleep expert Dr. Abhay Sharma talks about how Zepbound is now approved by the FDA for the treatment of moderate to severe ...
WRKF1h
Zyn nicotine pouches can be marketed in the U.S., the FDA says. What does this mean?
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...
24/7 Wall St2h
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Plastics News2h
FDA warns Hologic to do more to prevent harm from component in recalled implant markers
The U.S. Food and Drug Administration has sent a warning letter to Marlborough, Mass.-based medical technology company ...
The American Journal of Managed Care2h
FDA Approves Datopotamab Deruxtecan for HR-Positive/HER2-Negative Metastatic Breast Cancer
The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.
VERIFYING 4 claims about the FDA ban on red dye No. 3
VERIFY answers four questions about the common food additive red dye No. 3, including what products contain it and if the FDA ...
Targeted Oncology2h
FDA Approves Dato-DXd in HR+, HER2- Breast Cancer Following TROPION-Breast01
Virginia G. Kaklamani, MD, DSc, discusses findings from the phase 3 TROPION-Breast01 trial of datopotamab deruxtecan.